Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction

The effects of iron deficiency (ID) have been widely studied in heart failure (HF) with reduced ejection fraction. On the other hand, studies in HF with preserved ejection fraction (HFpEF) are few and have included small numbers of participants. The aim of this study was to assess the role that ID p...

Full description

Bibliographic Details
Main Authors: Alex Alcaide-Aldeano, Alberto Garay, Lídia Alcoberro, Santiago Jiménez-Marrero, Sergi Yun, Marta Tajes, Elena García-Romero, Carles Díez-López, José González-Costello, Gemma Mateus-Porta, Miguel Cainzos-Achirica, Cristina Enjuanes, Josep Comín-Colet, Pedro Moliner
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/4/1199
_version_ 1797569917136928768
author Alex Alcaide-Aldeano
Alberto Garay
Lídia Alcoberro
Santiago Jiménez-Marrero
Sergi Yun
Marta Tajes
Elena García-Romero
Carles Díez-López
José González-Costello
Gemma Mateus-Porta
Miguel Cainzos-Achirica
Cristina Enjuanes
Josep Comín-Colet
Pedro Moliner
author_facet Alex Alcaide-Aldeano
Alberto Garay
Lídia Alcoberro
Santiago Jiménez-Marrero
Sergi Yun
Marta Tajes
Elena García-Romero
Carles Díez-López
José González-Costello
Gemma Mateus-Porta
Miguel Cainzos-Achirica
Cristina Enjuanes
Josep Comín-Colet
Pedro Moliner
author_sort Alex Alcaide-Aldeano
collection DOAJ
description The effects of iron deficiency (ID) have been widely studied in heart failure (HF) with reduced ejection fraction. On the other hand, studies in HF with preserved ejection fraction (HFpEF) are few and have included small numbers of participants. The aim of this study was to assess the role that ID plays in functional capacity and quality of life (QoL) in HFpEF while comparing several iron-related biomarkers to be used as potential predictors. ID was defined as ferritin <100 ng/mL or transferrin saturation <20%. Submaximal exercise capacity, measured by the 6-min walking test (6MWT), and QoL, assessed by the Minnesotta Living with Heart Failure Questionnaire (MLHFQ), were compared between iron deficient patients and patients with normal iron status. A total of 447 HFpEF patients were included in the present cross-sectional study, and ID prevalence was 73%. Patients with ID performed worse in the 6MWT compared to patients with normal iron status (ID 271 ± 94 m vs. non-ID 310 ± 108 m, <i>p</i> < 0.01). They also scored higher in the MLHFQ, denoting worse QoL (ID 49 ± 22 vs. non-ID 43 ± 23, <i>p</i> = 0.01). Regarding iron metabolism biomarkers, serum soluble transferrin receptor (sTfR) was the strongest independent predictor of functional capacity (β = −63, <i>p</i> < 0.0001, R<sup>2</sup> 0.39) and QoL (β = 7.95, <i>p</i> < 0.0001, R<sup>2</sup> 0.14) in multivariate models. This study postulates that ID is associated with worse functional capacity and QoL in HFpEF as well, and that sTfR is the best iron-related biomarker to predict both. Our study also suggests that the effects of ID could differ among HFpEF patients by left ventricular ejection fraction.
first_indexed 2024-03-10T20:18:05Z
format Article
id doaj.art-2952a13593244948878531be2a332719
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T20:18:05Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-2952a13593244948878531be2a3327192023-11-19T22:22:39ZengMDPI AGJournal of Clinical Medicine2077-03832020-04-0194119910.3390/jcm9041199Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection FractionAlex Alcaide-Aldeano0Alberto Garay1Lídia Alcoberro2Santiago Jiménez-Marrero3Sergi Yun4Marta Tajes5Elena García-Romero6Carles Díez-López7José González-Costello8Gemma Mateus-Porta9Miguel Cainzos-Achirica10Cristina Enjuanes11Josep Comín-Colet12Pedro Moliner13University of Barcelona, School of Medicine, 08036 Barcelona, SpainCommunity Heart Failure Unit, Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, SpainCommunity Heart Failure Unit, Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, SpainCommunity Heart Failure Unit, Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, SpainCommunity Heart Failure Unit, Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, SpainCommunity Heart Failure Unit, Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, SpainBellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, 08907 Barcelona, SpainBellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, 08907 Barcelona, SpainUniversity of Barcelona, School of Medicine, 08036 Barcelona, SpainDepartment of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, SpainJohns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology Johns Hopkins University School of Medicine, Baltimore, MD 21287, USACommunity Heart Failure Unit, Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, SpainUniversity of Barcelona, School of Medicine, 08036 Barcelona, SpainCommunity Heart Failure Unit, Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, SpainThe effects of iron deficiency (ID) have been widely studied in heart failure (HF) with reduced ejection fraction. On the other hand, studies in HF with preserved ejection fraction (HFpEF) are few and have included small numbers of participants. The aim of this study was to assess the role that ID plays in functional capacity and quality of life (QoL) in HFpEF while comparing several iron-related biomarkers to be used as potential predictors. ID was defined as ferritin <100 ng/mL or transferrin saturation <20%. Submaximal exercise capacity, measured by the 6-min walking test (6MWT), and QoL, assessed by the Minnesotta Living with Heart Failure Questionnaire (MLHFQ), were compared between iron deficient patients and patients with normal iron status. A total of 447 HFpEF patients were included in the present cross-sectional study, and ID prevalence was 73%. Patients with ID performed worse in the 6MWT compared to patients with normal iron status (ID 271 ± 94 m vs. non-ID 310 ± 108 m, <i>p</i> < 0.01). They also scored higher in the MLHFQ, denoting worse QoL (ID 49 ± 22 vs. non-ID 43 ± 23, <i>p</i> = 0.01). Regarding iron metabolism biomarkers, serum soluble transferrin receptor (sTfR) was the strongest independent predictor of functional capacity (β = −63, <i>p</i> < 0.0001, R<sup>2</sup> 0.39) and QoL (β = 7.95, <i>p</i> < 0.0001, R<sup>2</sup> 0.14) in multivariate models. This study postulates that ID is associated with worse functional capacity and QoL in HFpEF as well, and that sTfR is the best iron-related biomarker to predict both. Our study also suggests that the effects of ID could differ among HFpEF patients by left ventricular ejection fraction.https://www.mdpi.com/2077-0383/9/4/1199heart failure with preserved ejection fractionHFpEFiron deficiencyquality of lifesubmaximal exercise capacity6-min walking test
spellingShingle Alex Alcaide-Aldeano
Alberto Garay
Lídia Alcoberro
Santiago Jiménez-Marrero
Sergi Yun
Marta Tajes
Elena García-Romero
Carles Díez-López
José González-Costello
Gemma Mateus-Porta
Miguel Cainzos-Achirica
Cristina Enjuanes
Josep Comín-Colet
Pedro Moliner
Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
Journal of Clinical Medicine
heart failure with preserved ejection fraction
HFpEF
iron deficiency
quality of life
submaximal exercise capacity
6-min walking test
title Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
title_full Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
title_fullStr Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
title_full_unstemmed Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
title_short Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
title_sort iron deficiency impact on functional capacity and quality of life in heart failure with preserved ejection fraction
topic heart failure with preserved ejection fraction
HFpEF
iron deficiency
quality of life
submaximal exercise capacity
6-min walking test
url https://www.mdpi.com/2077-0383/9/4/1199
work_keys_str_mv AT alexalcaidealdeano irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT albertogaray irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT lidiaalcoberro irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT santiagojimenezmarrero irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT sergiyun irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT martatajes irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT elenagarciaromero irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT carlesdiezlopez irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT josegonzalezcostello irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT gemmamateusporta irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT miguelcainzosachirica irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT cristinaenjuanes irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT josepcomincolet irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction
AT pedromoliner irondeficiencyimpactonfunctionalcapacityandqualityoflifeinheartfailurewithpreservedejectionfraction